China Healthwise Holdings Limited provided unaudited consolidated group earnings guidance for the half year of 2022. For the period, the group expects to record a loss attributable to owners of the Company within a range of approximately HKD 15 million to approximately HKD 23 million, as compared to a profit attributable to owners of the Company of HKD 37 million for the half year of 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.059 HKD | +3.51% | -15.71% | +43.90% |
Mar. 26 | China Healthwise Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 21 | China Healthwise to Widen Losses in 2023 | MT |
1st Jan change | Capi. | |
---|---|---|
+43.90% | 5.82M | |
-4.38% | 23.48B | |
+4.16% | 8.51B | |
+9.26% | 8.42B | |
-24.53% | 7.56B | |
+13.31% | 5.22B | |
0.00% | 4.2B | |
-1.31% | 3.91B | |
+6.13% | 3.91B | |
+21.14% | 3.61B |
- Stock Market
- Equities
- 348 Stock
- News China Healthwise Holdings Limited
- China Healthwise Holdings Limited Provides Unaudited Consolidated Group Earnings Guidance for the Half Year of 2022